The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial

The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manife...

Descripción completa

Detalles Bibliográficos
Autores principales: Adas, G, Cukurova, Z, Yasar, K Kart, Yilmaz, R, Isiksacan, N, Kasapoglu, P, Yesilbag, Z, Koyuncu, ID, Karaoz, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243094/
https://www.ncbi.nlm.nih.gov/pubmed/34180719
http://dx.doi.org/10.1177/09636897211024942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243094/
https://www.ncbi.nlm.nih.gov/pubmed/34180719
http://dx.doi.org/10.1177/09636897211024942

Ejemplares similares